Loading…
Osteoarthritis in the cat: 2. How should it be managed and treated?
Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challen...
Saved in:
Published in: | Journal of feline medicine and surgery 2012, Vol.14 (1), p.76-84 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3 |
container_end_page | 84 |
container_issue | 1 |
container_start_page | 76 |
container_title | Journal of feline medicine and surgery |
container_volume | 14 |
creator | Bennett, David Zainal Ariffin, Siti Mariam bt Johnston, Pamela |
description | Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challenge and many analgesic drugs used in other species are not licensed, not available or not tested for use in the cat. Many older cats with painful OA have some degree of chronic kidney disease (CKD) and many clinicians are reluctant to use non-steroidal anti-inflammatory drugs (NSAIDs) in these animals because of the potential for nephrotoxicity. Evidence base There are several publications that show that meloxicam is an effective NSAID for the cat and can be used long-term. It is easy to administer and there is published evidence that meloxicam can actually slow the progression of CKD in this species. Many other drugs are used to treat chronic pain in the cat but there is no documented evidence of their efficacy in OA. Unlike the dog, there is limited evidence for the effectiveness of omega-3 fatty acid-rich diets in managing feline OA and further work is required. There is no published data as yet for the usefulness or otherwise of nutraceuticals (glucosamine and chondroitin) in managing feline OA; studies in the authors’ clinic suggest some pain-relieving effect. Research into environmental enrichment as a way of improving quality of life in cats with painful OA is lacking, but it is an approach worth using where possible. Modifications to the environment (eg, provision of comfortable bedding and ramps) are also important. |
doi_str_mv | 10.1177/1098612X11432829 |
format | article |
fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11148914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1098612X11432829</sage_id><sourcerecordid>916521593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3</originalsourceid><addsrcrecordid>eNp9kUtLxDAURoMoPkb3rjQ7Vx3zaNrGjcjgCwQXKrgLt-2dmUin0SRV_PdmGBV14SqB79wvyQkh-5yNOS_LY850VXDxyHkuRSX0GtnmSopMlIqtp32Ks2W-RXZCeGKMaanFJtkSQuSlFOU2mdyGiA58nHsbbaC2p3GOtIF4QsWYXrk3GuZu6FpqI62RLqCHGbYU-pZGjxCxPd0lG1PoAu59riPycHF-P7nKbm4vrydnN1kjCx2ztiyUklMNedMWWOo6Z3lbqVyC4o1EKJQuAJXEos5BVbJWTCvdlJwt31SBHJHTVe_zUC-wbbCPHjrz7O0C_LtxYM3vpLdzM3Ovhic_lU6ORuTos8G7lwFDNAsbGuw66NENwWheKMGVlolkK7LxLgSP0-9jODNL9-av-zRy8PN63wNfshOQrYCQFJonN_g-6fqv8HDFT8EZmHkbzMOdYDxPH8mTFSk_AAvik7Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>916521593</pqid></control><display><type>article</type><title>Osteoarthritis in the cat: 2. How should it be managed and treated?</title><source>SAGE Journals</source><creator>Bennett, David ; Zainal Ariffin, Siti Mariam bt ; Johnston, Pamela</creator><creatorcontrib>Bennett, David ; Zainal Ariffin, Siti Mariam bt ; Johnston, Pamela</creatorcontrib><description>Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challenge and many analgesic drugs used in other species are not licensed, not available or not tested for use in the cat. Many older cats with painful OA have some degree of chronic kidney disease (CKD) and many clinicians are reluctant to use non-steroidal anti-inflammatory drugs (NSAIDs) in these animals because of the potential for nephrotoxicity. Evidence base There are several publications that show that meloxicam is an effective NSAID for the cat and can be used long-term. It is easy to administer and there is published evidence that meloxicam can actually slow the progression of CKD in this species. Many other drugs are used to treat chronic pain in the cat but there is no documented evidence of their efficacy in OA. Unlike the dog, there is limited evidence for the effectiveness of omega-3 fatty acid-rich diets in managing feline OA and further work is required. There is no published data as yet for the usefulness or otherwise of nutraceuticals (glucosamine and chondroitin) in managing feline OA; studies in the authors’ clinic suggest some pain-relieving effect. Research into environmental enrichment as a way of improving quality of life in cats with painful OA is lacking, but it is an approach worth using where possible. Modifications to the environment (eg, provision of comfortable bedding and ramps) are also important.</description><identifier>ISSN: 1098-612X</identifier><identifier>ISSN: 1532-2750</identifier><identifier>EISSN: 1532-2750</identifier><identifier>DOI: 10.1177/1098612X11432829</identifier><identifier>PMID: 22247327</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>analgesic effect ; analgesics ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Cat Diseases - therapy ; Cats ; Clinical Reviews ; diet ; dogs ; environmental enrichment ; Evidence-Based Medicine ; kidneys ; Meloxicam ; nephrotoxicity ; nonsteroidal anti-inflammatory agents ; osteoarthritis ; Osteoarthritis - therapy ; Osteoarthritis - veterinary ; pain ; quality of life ; Thiazines - therapeutic use ; Thiazoles - therapeutic use</subject><ispartof>Journal of feline medicine and surgery, 2012, Vol.14 (1), p.76-84</ispartof><rights>International Society of Feline Medicine and American Association of Feline Practitioners 2012</rights><rights>International Society of Feline Medicine and American Association of Feline Practitioners 2012 2012 International Society of Feline Medicine and American Association of Feline Practitioners</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148914/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148914/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,21966,27853,27923,27924,27925,44945,45333,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/1098612X11432829?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22247327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bennett, David</creatorcontrib><creatorcontrib>Zainal Ariffin, Siti Mariam bt</creatorcontrib><creatorcontrib>Johnston, Pamela</creatorcontrib><title>Osteoarthritis in the cat: 2. How should it be managed and treated?</title><title>Journal of feline medicine and surgery</title><addtitle>J Feline Med Surg</addtitle><description>Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challenge and many analgesic drugs used in other species are not licensed, not available or not tested for use in the cat. Many older cats with painful OA have some degree of chronic kidney disease (CKD) and many clinicians are reluctant to use non-steroidal anti-inflammatory drugs (NSAIDs) in these animals because of the potential for nephrotoxicity. Evidence base There are several publications that show that meloxicam is an effective NSAID for the cat and can be used long-term. It is easy to administer and there is published evidence that meloxicam can actually slow the progression of CKD in this species. Many other drugs are used to treat chronic pain in the cat but there is no documented evidence of their efficacy in OA. Unlike the dog, there is limited evidence for the effectiveness of omega-3 fatty acid-rich diets in managing feline OA and further work is required. There is no published data as yet for the usefulness or otherwise of nutraceuticals (glucosamine and chondroitin) in managing feline OA; studies in the authors’ clinic suggest some pain-relieving effect. Research into environmental enrichment as a way of improving quality of life in cats with painful OA is lacking, but it is an approach worth using where possible. Modifications to the environment (eg, provision of comfortable bedding and ramps) are also important.</description><subject>analgesic effect</subject><subject>analgesics</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Cat Diseases - therapy</subject><subject>Cats</subject><subject>Clinical Reviews</subject><subject>diet</subject><subject>dogs</subject><subject>environmental enrichment</subject><subject>Evidence-Based Medicine</subject><subject>kidneys</subject><subject>Meloxicam</subject><subject>nephrotoxicity</subject><subject>nonsteroidal anti-inflammatory agents</subject><subject>osteoarthritis</subject><subject>Osteoarthritis - therapy</subject><subject>Osteoarthritis - veterinary</subject><subject>pain</subject><subject>quality of life</subject><subject>Thiazines - therapeutic use</subject><subject>Thiazoles - therapeutic use</subject><issn>1098-612X</issn><issn>1532-2750</issn><issn>1532-2750</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kUtLxDAURoMoPkb3rjQ7Vx3zaNrGjcjgCwQXKrgLt-2dmUin0SRV_PdmGBV14SqB79wvyQkh-5yNOS_LY850VXDxyHkuRSX0GtnmSopMlIqtp32Ks2W-RXZCeGKMaanFJtkSQuSlFOU2mdyGiA58nHsbbaC2p3GOtIF4QsWYXrk3GuZu6FpqI62RLqCHGbYU-pZGjxCxPd0lG1PoAu59riPycHF-P7nKbm4vrydnN1kjCx2ztiyUklMNedMWWOo6Z3lbqVyC4o1EKJQuAJXEos5BVbJWTCvdlJwt31SBHJHTVe_zUC-wbbCPHjrz7O0C_LtxYM3vpLdzM3Ovhic_lU6ORuTos8G7lwFDNAsbGuw66NENwWheKMGVlolkK7LxLgSP0-9jODNL9-av-zRy8PN63wNfshOQrYCQFJonN_g-6fqv8HDFT8EZmHkbzMOdYDxPH8mTFSk_AAvik7Y</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Bennett, David</creator><creator>Zainal Ariffin, Siti Mariam bt</creator><creator>Johnston, Pamela</creator><general>SAGE Publications</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2012</creationdate><title>Osteoarthritis in the cat: 2. How should it be managed and treated?</title><author>Bennett, David ; Zainal Ariffin, Siti Mariam bt ; Johnston, Pamela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>analgesic effect</topic><topic>analgesics</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Cat Diseases - therapy</topic><topic>Cats</topic><topic>Clinical Reviews</topic><topic>diet</topic><topic>dogs</topic><topic>environmental enrichment</topic><topic>Evidence-Based Medicine</topic><topic>kidneys</topic><topic>Meloxicam</topic><topic>nephrotoxicity</topic><topic>nonsteroidal anti-inflammatory agents</topic><topic>osteoarthritis</topic><topic>Osteoarthritis - therapy</topic><topic>Osteoarthritis - veterinary</topic><topic>pain</topic><topic>quality of life</topic><topic>Thiazines - therapeutic use</topic><topic>Thiazoles - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bennett, David</creatorcontrib><creatorcontrib>Zainal Ariffin, Siti Mariam bt</creatorcontrib><creatorcontrib>Johnston, Pamela</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of feline medicine and surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bennett, David</au><au>Zainal Ariffin, Siti Mariam bt</au><au>Johnston, Pamela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteoarthritis in the cat: 2. How should it be managed and treated?</atitle><jtitle>Journal of feline medicine and surgery</jtitle><addtitle>J Feline Med Surg</addtitle><date>2012</date><risdate>2012</risdate><volume>14</volume><issue>1</issue><spage>76</spage><epage>84</epage><pages>76-84</pages><issn>1098-612X</issn><issn>1532-2750</issn><eissn>1532-2750</eissn><abstract>Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challenge and many analgesic drugs used in other species are not licensed, not available or not tested for use in the cat. Many older cats with painful OA have some degree of chronic kidney disease (CKD) and many clinicians are reluctant to use non-steroidal anti-inflammatory drugs (NSAIDs) in these animals because of the potential for nephrotoxicity. Evidence base There are several publications that show that meloxicam is an effective NSAID for the cat and can be used long-term. It is easy to administer and there is published evidence that meloxicam can actually slow the progression of CKD in this species. Many other drugs are used to treat chronic pain in the cat but there is no documented evidence of their efficacy in OA. Unlike the dog, there is limited evidence for the effectiveness of omega-3 fatty acid-rich diets in managing feline OA and further work is required. There is no published data as yet for the usefulness or otherwise of nutraceuticals (glucosamine and chondroitin) in managing feline OA; studies in the authors’ clinic suggest some pain-relieving effect. Research into environmental enrichment as a way of improving quality of life in cats with painful OA is lacking, but it is an approach worth using where possible. Modifications to the environment (eg, provision of comfortable bedding and ramps) are also important.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>22247327</pmid><doi>10.1177/1098612X11432829</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1098-612X |
ispartof | Journal of feline medicine and surgery, 2012, Vol.14 (1), p.76-84 |
issn | 1098-612X 1532-2750 1532-2750 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11148914 |
source | SAGE Journals |
subjects | analgesic effect analgesics Animals Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Cat Diseases - therapy Cats Clinical Reviews diet dogs environmental enrichment Evidence-Based Medicine kidneys Meloxicam nephrotoxicity nonsteroidal anti-inflammatory agents osteoarthritis Osteoarthritis - therapy Osteoarthritis - veterinary pain quality of life Thiazines - therapeutic use Thiazoles - therapeutic use |
title | Osteoarthritis in the cat: 2. How should it be managed and treated? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A39%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteoarthritis%20in%20the%20cat:%202.%20How%20should%20it%20be%20managed%20and%20treated?&rft.jtitle=Journal%20of%20feline%20medicine%20and%20surgery&rft.au=Bennett,%20David&rft.date=2012&rft.volume=14&rft.issue=1&rft.spage=76&rft.epage=84&rft.pages=76-84&rft.issn=1098-612X&rft.eissn=1532-2750&rft_id=info:doi/10.1177/1098612X11432829&rft_dat=%3Cproquest_AFRWT%3E916521593%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=916521593&rft_id=info:pmid/22247327&rft_sage_id=10.1177_1098612X11432829&rfr_iscdi=true |